As biotechnology continues to accelerate globally, GeneFerm is advancing R&D and process innovation by focusing on two high-barrier core areas: anaerobic microbial fermentation and precision fermentation, reinforcing its technical leadership and global competitiveness.

Strict anaerobic strains are extremely sensitive to oxygen, temperature, and humidity—requiring fully controlled, oxygen-free environments throughout cultivation, fermentation, freeze-drying, and packaging. Only a few companies worldwide have the capabilities to achieve stable mass production in this field, and GeneFerm is one of them.

In parallel, GeneFerm is actively developing precision fermentation technologies, leveraging microbes as cell factories to produce high-value functional ingredients. This enables reliable, consistent sourcing and addresses critical issues in the industrial supply chain.

GeneFerm has established a scalable fermentation platform that meets international quality standards, offering integrated and flexible CDMO services. Moving forward, the company will continue to promote microbial innovation, drive cross-industry applications, and uphold its commitment to sustainability and eco-friendly manufacturing.

GeneFerm — not just fermentation, but expanding the future of microbial innovation.